|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01346397 |
|
Date of registration:
|
07/07/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
RSCS-Campath |
|
Scientific title:
|
Prospective Randomized Trial Comparing CsA Versus Tacro After Campath Induction In Kidney Transplant Recipients |
|
Date of first enrolment:
|
September 2010 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01346397 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Russian Federation
| | | | | | | |
|
Contacts
|
|
Name:
|
Michael M. Kaabak, MD, PhD |
|
Address:
|
|
|
Telephone:
|
+74992481344 |
|
Email:
|
kaabak@hotmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Michael M Kaabak, professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Russian Scientific Center of Surgery RAMS |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- recipient of kidney allograft
- previous Campath induction
Exclusion Criteria:
- CNI intolerance
Age minimum:
6 Months
Age maximum:
60 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Acute Graft Rejection
|
|
Chronic Allograft Nephropathy
|
|
Polyomavirus-related Transplant Nephropathy
|
|
Secondary ID(s)
|
|
RSCS-Campath-06
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|